Detail akcie Adiuvo Invest online

Business Summary: Adiuvo Investments SA W Restrukturyzacji, formerly Adiuvo Investments SA is a Poland-based company engaged in the financial industry. The Company focuses on the selection, development, financing and commercialization of biomedical projects on the international market. By providing intellectual property protection, technology validation in clinical trials and obtaining certificates allowing products to market, Adiuvo Investments SA is able to commercialize projects in diverse business model and internationally. The Company is looking for and invests in projects in the segments of the nutraceutical, medical devices and the digital health. Its business portfolio encompasses Airway Medix, Algae Labs, Carocelle, Cambridge Chocolate Technology, Endomedical, Esthechoc, Glia, Joint Polish Investment Fund, Marmar Investment, Nanoxide and Peptaderm.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Adiuvo Investments SA W Restrukturyzacji revenues increased from PLN251K to PLN920K. Net loss applicable to common stockholders totaled PLN1.3M vs. income of PLN1.1M. Revenues reflect Medical Equipment segment increase from PLN0K to PLN918K, Other Segments increase from PLN0K to PLN2K. Net loss reflects Corrections/Eliminations segment income decrease of 91% to PLN167K.